ScanSource appears to be at an inflection point, with Q4 2026 revenue growth reaccelerating to 17.3% after four quarters of contraction, suggesting a recovery in hardware demand. The company's minimal leverage (D/E of 0.12) and consistent share repurchases pro...
Price trend, volume and key moving averages
Trailing total returns as of 9/23/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).
Check whether operating performance supports the current valuation.
Recent results and news deserve attention only when they alter the forward view.
| Quarter | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|
Q3 2026Latest Aug 20, 2026 | $1.46+28.1% vs $1.14 | $953M+17.0% vs $814M |
Q2 2026 May 7, 2026 | $0.94+3.3% vs $0.91 | $767M+3.8% vs $739M |
Q1 2026 Feb 5, 2026 | $0.80-20.0% vs $1.00 | $760M-2.7% vs $781M |
Q4 2025 Nov 6, 2025 | $1.06+16.5% vs $0.91 | $740M-5.7% vs $785M |
Hsbc Holdings PLC grew its stake in shares of ScanSource, Inc. (NASDAQ: SCSC) by 160.3% during the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 36,881 shares of the industrial products company's stock after purchasing an additional 22,715 shares during the period.
Investors looking for stocks in the Technology Services sector might want to consider either ScanSource (SCSC) or Everpure (P). But which of these two stocks is more attractive to value investors?
[url="]ScanSource, Inc.[/url] (NASDAQ: SCSC), a leading technology distributor uniquely positioned to address complex technologies, today announced the successf
GREENVILLE, S.C.--(BUSINESS WIRE)--ScanSource, Inc. (NASDAQ: SCSC), a leading technology distributor uniquely positioned to address complex technologies, today announced the successful completion of its acquisition of MicroAge, pursuant to the definitive agreement previously announced on August 20, 2026. “The acquisition of MicroAge marks an exciting milestone in ScanSource's growth journey,” said Mike Baur, Chair and CEO, ScanSource, Inc. "This transaction advances our strategic priorities and.
Benchmark SCSC against direct peers instead of judging its metrics in isolation.
Key metrics vs top competitors for ScanSource, Inc. (SCSC)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $57.75 | $1.17B | 19.25 | -6.72% | 2.35% | 7.82% | — | |
| $98.25 | $8.06B | 24.50 | 24.47% | 1.21% | 6.77% | — | |
| $221.83 | $11.34B | 20.30 | 10.49% | 2.26% | 12.01% | — | |
| $283.25 | $22.66B | 28.47 | 6.94% | 1.63% | 13.12% | — | |
| $156.25 | $4.72B | 32.15 | -5.22% | 2.45% | 13.08% | — | |
| $86.84 | $2.19B | 26.56 | 2.52% | 3.21% | 10.4% | — |
ScanSource, Inc. (SCSC) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Verify the primary filings, follow material updates, and answer the remaining questions.
ScanSource, Inc. (SCSC) SEC filings — annual & quarterly reports (10-K, 10-Q)
Sep 2, 2026·SEC
Aug 20, 2026·SEC
Aug 17, 2026·SEC
Get notified when SCSC posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
ScanSource, Inc. (SCSC) stock FAQ — growth, dividends, profitability & financials explained
ScanSource, Inc. (SCSC) reported $3.23B in revenue for fiscal year 2025. This represents a 5692% increase from $55.7M in 1996.
ScanSource, Inc. (SCSC) saw revenue decline by 6.7% over the past year.
Yes, ScanSource, Inc. (SCSC) is profitable, generating $78.9M in net income for fiscal year 2025 (2.4% net margin).
ScanSource, Inc. (SCSC) has a return on equity (ROE) of 7.8%. This is below average, suggesting room for improvement.
ScanSource, Inc. (SCSC) generated $113.8M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.
